9.21澳幣0.12(1.32%)
2023/03/17更新
績效 / 1月3.35%
3月4.48%
1年
晨星評等-
淨值走勢
持股明細 / 風險評估
- 1.美國47.69%
- 2.歐洲不包含歐元區12.76%
- 3.英國12.49%
- 4.歐元區7.76%
- 5.日本2.77%
- 1.健康護理65.29%
- 2.周期性消費6.58%
- 3.工業4.34%
- 4.金融服務3.17%
- 5.基本物料3.03%
- 1.Novo Nordisk A/S Class B6.56%
- 2.Johnson & Johnson5.21%
- 3.Quest Diagnostics Inc4.80%
- 4.UnitedHealth Group Inc4.69%
- 5.AstraZeneca PLC4.12%
- 1.美國47.69%
- 2.歐洲不包含歐元區12.76%
- 3.英國12.49%
- 4.歐元區7.76%
- 5.日本2.77%
- 1.Novo Nordisk A/S Class B6.56%
- 2.Johnson & Johnson5.21%
- 3.Quest Diagnostics Inc4.80%
- 4.UnitedHealth Group Inc4.69%
- 5.AstraZeneca PLC4.12%
- 1.健康護理65.29%
- 2.周期性消費6.58%
- 3.工業4.34%
- 4.金融服務3.17%
- 5.基本物料3.03%